Did the coronavirus leak from a Wuhan lab?

By the time you start reading this post or watch the latest podcast, your mind has probably been bombarded by an extraordinary amount of disinformation from the U.S. and China over whether the coronavirus leaked from a Chinese virology lab? China obviously denies this possibility but the US isn’t so sure.

The global dispute resulted in an extraordinarily rare statement from the director of national intelligence confirming the U.S. is exploring claims the coronavirus leaked from the Wuhan Institute of Virology.

My independent investigation reveals that while the virus appears to be naturally occurring, it likely originated from cultures in the high security P4 laboratory in Wuhan.

These are my findings.

Support Narativ’s independent journalism by joining Narativ at Patreon for as little s $5 a month. Click on the “become a patron” button above to join.

There is much more to the disinformation war than meets the eye. Trump’s claims are also a strategic attempt to paint Democrats and Joe Biden as soft on China.

“This is what happens in a disinformation war. Two sides that are involved in something together start pretending to fight with each other. We saw it in Syria when Russia accused Turkey of profiting off the sale of ISIS oil. The truth is that faux fight was a smokescreen to hide the fact that they were both profiting off the sale of ISIS oil in Syria. The same thing is happening here.”

“What Happened in Wuhan?”

The post What Happened In Wuhan? appeared first on Narativ.

The symmetry between Chinese President Xi and Donald Trump’s strategies is too hard to ignore. Are the two leaders intentionally sickening the world?

Over the last four years, many of us who write about the Trump administration have suspected that behind the Russian interference and the Saudi connection is a China rising story. Beijing’s involvement has been visible on the fringes, but there were limited apparent ties to the Trump Administration to arrive at a conclusive collusion story. 

As #COVID-19 has become an everyday reality for most of us, the symmetry between Trump and Xi’s strategy has become more apparent. In the latest podcast, I break down why I think Xi and Trump are deliberately sickening the world and why America remains completely divided by it. 

Support Narativ’s independent journalist by clicking the button above. Memberships start at just $5 a month.

Watch the Narativ podcast above or on the podcast app of any Apple iOS device. You can listen to the podcast on most podcast apps like Spotify or Stitcher.

The post appeared first on Narativ.

Does SARS-CoV-2 slow down during Summer?

The National Academy of Sciences‘ Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats has weighed in on the question: Does the spread of the Coronavirus slow down in warmer conditions?

NAS claims studies have shown reduced transmission of the virus under warmer and humid conditions in the lab. One study found the virus does survive longer than other known pathogens like flu, monkeypox, tuberculosis or the 2002 SARS but still less than in colder conditions.

Out of the lab, the virus still spreads in countries with warmer weather but the countries with the biggest outbreaks all occurred during the northern Winter and early Spring and have subsided as the temperatures climbed.

More people are outside in the Summer which may help social distancing.

The unknown factor is the limited research into the two strains of SARS-CoV-2. One strain appears to have been more dominant in Europe and the East Coast of the USA and the other in Asia.

Here’s the National Academy of Sciences report on the Coronavirus survival in Summer.

Google has published a fully interactive map which allows local newsrooms (and anyone else frankly) access to a real-time visualization of COVID-19’s contagion in their local districts or anywhere in the U.S.

The post Coronavirus In Summer appeared first on Narativ.

As COVID-19 came to America, Donald Trump and Jared Kushner saw dollars not deaths.

For three critical weeks beginning in February, the White House could have stopped the spread of the coronavirus.

My investigation reveals Intelligence and National Security Council officials briefed Donald Trump about the scale and severity of the looming outbreak in January. Yet he officially failed to react and publicly denied the threat.

By February 24, as the stock market tumbled on the news the coronavirus had spread outside of China’s borders, to South Korea, Iran, and the U.S., Trump remained inexplicably in denial.

It took Trump until March 13 for Trump to declare the pandemic a national emergency, 19 days after the financial markets began their retreat.

Instead of putting America on a war footing, Trump kept talking down the severity of the coronavirus, calling it a hoax and downplaying the actual numbers and projections his advisers were giving him.

Those 19 days when Trump fiddled, could have saved America from this crisis.

TRUMP IN DENIAL AS COVID-19 SPREAD

On February 24, there were 15 confirmed cases of Americans with COVID-19. By March 13, the figure was 2163. There is no doubt that a more prompt and deliberate response to contain the virus would have suppressed its growth trajectory significantly.

South Korean officials acted decisively after their first COVID-19 case on January 20, diagnosed on the same day the U.S. had its first confirmed case.

The South Koreans began testing symptomatic cases, contact tracing anyone who was potentially infected and isolating suspected cases. As a result, the spread of the virus in South Korea was dramatically slowed.

The opposite was playing out in the United States. Trump declared the coronavirus “very much under control in the U.S.A.” when in reality it was spreading without any attempts to contain it on the ground. A ban on travel from China was instituted.

Yet even as he was downplaying the virus publicly, Trump was engaged behind the scenes as American pharmaceutical companies were bidding to acquire test manufacturers and vaccine makers. One of those companies doing the buying was Thermo Fisher Scientific.

On March 3, Thermo Fisher Scientific completed a $10 Bn acquisition of Qiagen, A Dutch company that developed a COVID-19 test.

CONFLICT OF INTEREST

Ten days later, On March 13, Trump’s opinion of the looming crisis suddenly shifted, and he declared the coronavirus pandemic a national emergency.

The declaration allows the FDA and other government agencies to circumvent usual regulations for drug and test approvals.

Trump mentioned Thermo Fisher by name when he announced the national emergency, adding that FDA approval would not be far behind. It wan’t. Thermo Fisher’s test kits were approved by the FDA within 24 hours.

There are troubling murmurs of a conflict of interest but nothing iron-clad.

Trump owned shares in Thermo Fisher before becoming president. He says he divested them in 2017, but Trump may still hold them via a trust.

The CEO of Thermo Fisher’s China division, Gianluca Pettiti, was also one of 20 U.S. business leaders who attended a banquet for Trump and Melania during their 2017 state visit. In a social media post, President Xi is visible just feet away from Pettiti and Trump.

It’s hard to account for Trump’s coronavirus about-face: from hoax to national emergency within days. Some argue Trump was just being overly reassuring to Americans in the early stages, but how does that account for his lack of attention to disaster prevention?

The coronavirus and other bio-agents represent a brand new multi-billion dollar pharmaceutical sector. Thermo Fisher for example, intends to make 5 million COVID-19 tests a month. They will charge medicare $51 for each test (up from the CDC’s $31). That’s $3 Billion per year based on the Medicare price alone, which is vastly lower than other providers. And the taxpayers will shoulder the difference in cost.

Interestingly, Thermo Fisher also has ties to the Koch Brothers. Tyler Jacks headed the late David Koch’s cancer foundation at MIT. Jacks sits on the board of directors and the advisory board of Thermo Fisher.

Beyond testing, vaccines, masks, protective equipment, and surveillance tech represent other potential growth markets in this new sector. It’s not hard to see how the war against viruses will become the new war against terror.

While Trump managed Thermo Fisher’s FDA approval, he was also actively pursuing potential suitors of vaccine makers from around the world.

The CEO of Germany’s CureVac visited the White House on March 2. A visit arranged with just 24 hours notice. He was publicly fired a week later amid allegations Trump tried to buy the company’s vaccine production for the exclusive use of Americans, a claim which has been widely disputed.

It’s unlikely that CureVac will sell its entire vaccine supply to any country, let alone America. Still, there are 51 other vaccine studies around the world, and the first to market stands to make its owners a fortune. This is the race to watch as the sector heats up.

We also found out this week, Jared Kushner’s much-vaunted Google website initiative was neither successful nor Google’s. Jared’s brother’s health care company, Oscar, developed the site. Jared was a shareholder in the company until he allegedly disinvested from it.

While Donald Trump’s response to COVID-19 has been an unmitigated disaster, an unmistakable pattern of Trump’s hyper-focus on dealmaking rather than disaster response has emerged.

Trump is so fixated on being America’s CEO; he’s failed at the most crucial role of being its president: saving American lives.

The post Virus, Inc. appeared first on Narativ.